AAAAAA

   
Results: 1-25 | 26-30
Results: 1-25/30
Dendritic cell differentiation from hematopoietic CD34(+) progenitor cells
Authors: Curti, A Fogli, M Ratta, M Biasco, G Tura, S Lemoli, RM
Citation: A. Curti et al., Dendritic cell differentiation from hematopoietic CD34(+) progenitor cells, J BIOL REG, 15(1), 2001, pp. 49-52
Long-term follow-up of idiopathic thrombocytopenic purpura in 310 patients
Authors: Vianelli, N Valdre, L Fiacchini, M de Vivo, A Gugliotta, L Catani, L Lemoli, RM Poli, M Tura, S
Citation: N. Vianelli et al., Long-term follow-up of idiopathic thrombocytopenic purpura in 310 patients, HAEMATOLOG, 86(5), 2001, pp. 504-509
Double reinforcement with fludarabine/high-dose cytarabine enhances the impact of autologous stem cell transplantation in acute myeloid leukemia patients
Authors: Visani, G Lemoli, RM Isidori, A Piccaluga, PP Martinelli, G Malagola, M Gugliotta, L Bonini, A Bonifazi, F Motta, MR Rizzi, S Castellani, S Tura, S
Citation: G. Visani et al., Double reinforcement with fludarabine/high-dose cytarabine enhances the impact of autologous stem cell transplantation in acute myeloid leukemia patients, BONE MAR TR, 27(8), 2001, pp. 829-835
Immunotoxins containing recombinant anti-CTLA-4 single-chain fragment variable antibodies and saporin: In vitro results and in vivo effects in an acute rejection model
Authors: Tazzari, PL Polito, L Bolognesi, A Pistillo, MP Capanni, P Palmisano, GL Lemoli, RM Curti, A Biancone, L Camussi, G Conte, R Ferrara, GB Stirpe, F
Citation: Pl. Tazzari et al., Immunotoxins containing recombinant anti-CTLA-4 single-chain fragment variable antibodies and saporin: In vitro results and in vivo effects in an acute rejection model, J IMMUNOL, 167(8), 2001, pp. 4222-4229
Stem cell factor and FLT3-ligand are strictly required to sustain the long-term expansion of primitive CD34(+)DR(-) dendritic cell precursors
Authors: Curti, A Fogli, M Ratta, M Tura, S Lemoli, RM
Citation: A. Curti et al., Stem cell factor and FLT3-ligand are strictly required to sustain the long-term expansion of primitive CD34(+)DR(-) dendritic cell precursors, J IMMUNOL, 166(2), 2001, pp. 848-854
Reduced susceptibility to apoptosis correlates with kinetic quiescence in disease progression of chronic lymphocytic leukaemia
Authors: Ricciardi, MR Petrucci, MT Gregorj, C Ariola, C Lemoli, RM Fogli, M Mauro, FR Cerretti, R Foa, R Mandelli, F Tafuri, A
Citation: Mr. Ricciardi et al., Reduced susceptibility to apoptosis correlates with kinetic quiescence in disease progression of chronic lymphocytic leukaemia, BR J HAEM, 113(2), 2001, pp. 391-399
Interleukin-11 induces Th2 polarization of human CD4(+) T cells
Authors: Curti, A Ratta, M Corinti, S Girolomoni, G Ricci, F Tazzari, P Siena, M Grande, A Fogli, M Tura, S Lemoli, RM
Citation: A. Curti et al., Interleukin-11 induces Th2 polarization of human CD4(+) T cells, BLOOD, 97(9), 2001, pp. 2758-2763
Thrombopoietin, interleukin-11, and early-acting megakaryocyte growth factors in human myeloid leukemia cells
Authors: Petrucci, MT Riccardi, MR Gregorj, C Ariola, C Mazzola, F Fogli, M Lemoli, RM Tafuri, A
Citation: Mt. Petrucci et al., Thrombopoietin, interleukin-11, and early-acting megakaryocyte growth factors in human myeloid leukemia cells, LEUK LYMPH, 40(1-2), 2000, pp. 179-190
Quantitative evaluation of BCR-ABL amount of transcript post mobilization with G-CSF of peripheral blood stem cells from chronic myeloid leukemia patients in cytogenetic response
Authors: Martinelli, G Montefusco, V Amabile, M Lemoli, RM Terragna, C Testoni, N Ottaviani, E Rosti, G De Vivo, A Rizzi, S Russo, D Bregoli, M Tura, S
Citation: G. Martinelli et al., Quantitative evaluation of BCR-ABL amount of transcript post mobilization with G-CSF of peripheral blood stem cells from chronic myeloid leukemia patients in cytogenetic response, LEUK LYMPH, 39(1-2), 2000, pp. 113-120
Molecular remission after allogeneic or autologous transplantation of hematopoietic stem cells for multiple myeloma
Authors: Martinelli, G Terragna, C Zamagni, E Ronconi, S Tosi, P Lemoli, RM Bandini, G Motta, MR Testoni, N Amabile, M Ottaviani, E Vianelli, N de Vivo, A Gozzetti, A Tura, S Cave, M
Citation: G. Martinelli et al., Molecular remission after allogeneic or autologous transplantation of hematopoietic stem cells for multiple myeloma, J CL ONCOL, 18(11), 2000, pp. 2273-2281
Polymerase chain reaction-based detection of minimal residual disease in multiple myeloma patients receiving allogeneic stem cell transplantation
Authors: Martinelli, G Terragna, C Zamagni, E Ronconi, S Tosi, P Lemoli, RM Bandini, G Testoni, N Amabile, M Ottaviani, E Buonamici, S Soverini, S Montefusco, V De Vivo, A Bonifazi, F Tura, S Cavo, M
Citation: G. Martinelli et al., Polymerase chain reaction-based detection of minimal residual disease in multiple myeloma patients receiving allogeneic stem cell transplantation, HAEMATOLOG, 85(9), 2000, pp. 930-934
Dendritic cells: specialized antigen presenting cells
Authors: Di Nicola, M Lemoli, RM
Citation: M. Di Nicola et Rm. Lemoli, Dendritic cells: specialized antigen presenting cells, HAEMATOLOG, 85(2), 2000, pp. 202-207
Antitumor vaccination: where we stand
Authors: Bocchia, M Bronte, V Colombo, MP De Vincentiis, A Di Nicola, M Forni, G Lanata, L Lemoli, RM Massaia, M Rondelli, D Zanon, P Tura, S
Citation: M. Bocchia et al., Antitumor vaccination: where we stand, HAEMATOLOG, 85(11), 2000, pp. 1172-1206
Kinetics variation of CD34(+) and CD34(+)CD90(+) in subjects following different mobilizing protocols
Authors: Tassi, C Tazzari, PL Lemoli, RM Ricci, F Tura, S Conte, R
Citation: C. Tassi et al., Kinetics variation of CD34(+) and CD34(+)CD90(+) in subjects following different mobilizing protocols, HAEMATOLOG, 85(10), 2000, pp. 1118-1120
Efficient presentation of tumor idiotype to autologous T cells by CD83(+) dendritic cells derived from highly purified circulating CD14(+) monocytes in multiple myeloma patients
Authors: Ratta, M Curti, A Fogli, M Pantucci, M Viscomi, G Tazzari, P Fagnoni, F Vescovini, R Sansoni, P Tura, S Lemoli, RM
Citation: M. Ratta et al., Efficient presentation of tumor idiotype to autologous T cells by CD83(+) dendritic cells derived from highly purified circulating CD14(+) monocytes in multiple myeloma patients, EXP HEMATOL, 28(8), 2000, pp. 931-940
Transforming growth factor beta(3) inhibits chronic myelogenous leukemia hematopoiesis by inducing Fas-independent apoptosis
Authors: Fogli, M Carlo-Stella, C Curti, A Ratta, M Tazzari, P Ragazzi, E Colla, S Santucci, AM Tura, S Lemoli, RM
Citation: M. Fogli et al., Transforming growth factor beta(3) inhibits chronic myelogenous leukemia hematopoiesis by inducing Fas-independent apoptosis, EXP HEMATOL, 28(7), 2000, pp. 775-783
In vitro anti-tumour activity of anti-CD80 and anti-CD86 immunotoxins containing type 1 ribosome-inactivating proteins
Authors: Bolognesi, A Polito, L Tazzari, PL Lemoli, RM Lubelli, C Fogli, M Boon, L De Boer, M Stirpe, F
Citation: A. Bolognesi et al., In vitro anti-tumour activity of anti-CD80 and anti-CD86 immunotoxins containing type 1 ribosome-inactivating proteins, BR J HAEM, 110(2), 2000, pp. 351-361
Molecular monitoring of minimal residual disease in patients in long-term complete remission after allogeneic stem cell transplantation for multiple myeloma
Authors: Cavo, M Terragna, C Martinelli, G Ronconi, S Zamagni, E Tosi, P Lemoli, RM Benni, M Pagliani, G Bandini, G Tura, S
Citation: M. Cavo et al., Molecular monitoring of minimal residual disease in patients in long-term complete remission after allogeneic stem cell transplantation for multiple myeloma, BLOOD, 96(1), 2000, pp. 355
Engraftment, clinical, and molecular follow-up of patients with multiple myeloma who were reinfused with highly purified CD34+cells to support singleor tandem high-dose chemotherapy
Authors: Lemoli, RM Martinelli, G Zamagni, E Motta, MR Rizzi, S Terragna, C Rondelli, R Ronconi, S Curti, A Bonifazi, F Tura, S Cavo, M
Citation: Rm. Lemoli et al., Engraftment, clinical, and molecular follow-up of patients with multiple myeloma who were reinfused with highly purified CD34+cells to support singleor tandem high-dose chemotherapy, BLOOD, 95(7), 2000, pp. 2234-2239
Negative selection of autologous peripheral blood stem cells
Authors: Lemoli, RM Curti, A Tura, S
Citation: Rm. Lemoli et al., Negative selection of autologous peripheral blood stem cells, BAIL CLIN H, 12(1-2), 1999, pp. 57-69
Clinical and molecular follow-up by amplification of the CDR-III IgH region in multiple myeloma patients after autologous transplantation of hematopoietic CD34(+) stem cells
Authors: Martinelli, C Terragna, C Lemoli, RM Cavo, M Benni, M Motta, MR Amabile, M Ottaviani, E Testoni, N De Vivo, A Tura, S
Citation: C. Martinelli et al., Clinical and molecular follow-up by amplification of the CDR-III IgH region in multiple myeloma patients after autologous transplantation of hematopoietic CD34(+) stem cells, HAEMATOLOG, 84(5), 1999, pp. 397-404
Cell therapy: achievements and perspectives
Authors: Bordignon, C Carlo-Stella, C Colombo, MP De Vincentiis, A Lanata, L Lemoli, RM Locatelli, F Olivieri, A Rondelli, D Zanon, P Tura, S
Citation: C. Bordignon et al., Cell therapy: achievements and perspectives, HAEMATOLOG, 84(12), 1999, pp. 1110-1149
Thrombopoietin and interleukin 11 have different modulatory effects on cell cycle and programmed cell death in primary acute myeloid leukemia cells
Authors: Tafuri, A Lemoli, RM Petrucci, MT Ricciardi, MR Fogli, M Bonsi, L Ariola, C Strippoli, P Gregorj, C Petti, MC Tura, S Mandelli, F Bagnara, GP
Citation: A. Tafuri et al., Thrombopoietin and interleukin 11 have different modulatory effects on cell cycle and programmed cell death in primary acute myeloid leukemia cells, EXP HEMATOL, 27(8), 1999, pp. 1255-1263
Use of peripheral blood stem cells for autologous transplantation in acutemyeloid leukemia patients allows faster engraftment and equivalent disease-free survival compared with bone marrow cells
Authors: Visani, G Lemoli, RM Tosi, P Martinelli, G Testoni, N Ricci, P Motta, MR Gherlinzoni, F Leopardi, G Pastano, R Rizzi, S Piccaluga, PP Isidori, A Tura, S
Citation: G. Visani et al., Use of peripheral blood stem cells for autologous transplantation in acutemyeloid leukemia patients allows faster engraftment and equivalent disease-free survival compared with bone marrow cells, BONE MAR TR, 24(5), 1999, pp. 467-472
Characterization of autotransplant-related thrombocytopenia by evaluation of glycocalicin and reticulated platelets
Authors: Catani, L Vianelli, N Luatti, S Rizzi, S Castellani, S Valdre, L Lemoli, RM Tura, S
Citation: L. Catani et al., Characterization of autotransplant-related thrombocytopenia by evaluation of glycocalicin and reticulated platelets, BONE MAR TR, 24(11), 1999, pp. 1191-1194
Risultati: 1-25 | 26-30